Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PERGOLIDE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 186 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Lee, KA; Zaffke, ME; Baratte-Beebe, K
      Restless legs syndrome and sleep disturbance during pregnancy: The role offolate and iron

      JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE
    2. Glasauer, FE
      Restless legs syndrome

      SPINAL CORD
    3. Oertel, WH
      Overview and introduction: conquering nocturnal complications in Parkinson's disease and restless legs syndrome - the role of continuous dopaminergicstimulation

      EUROPEAN JOURNAL OF NEUROLOGY
    4. Stiasny, K
      Handling the problem of augmentation in restless legs syndrome (RLS)

      EUROPEAN JOURNAL OF NEUROLOGY
    5. Shimbo, T; Hira, K; Takemura, M; Fukui, T
      Cost-effectiveness analysis of dopamine agonists in the treatment of Parkinson's disease in Japan

      PHARMACOECONOMICS
    6. Malcolm, R; Herron, J; Sutherland, SE; Brady, KT
      Adverse outcomes in a controlled trial of pergolide for cocaine dependence

      JOURNAL OF ADDICTIVE DISEASES
    7. Koller, W; Lees, A; Doder, M; Hely, M
      Randomized trial of tolcapone versus pergolide as add-on to levodopa therapy in Parkinson's disease patients with motor fluctuations

      MOVEMENT DISORDERS
    8. Tergau, F; Wischer, S; Wolf, C; Paulus, W
      Treatment of restless legs syndrome with the dopamine agonist alpha-dihydroergocryptine

      MOVEMENT DISORDERS
    9. Jankovic, J; Tan, EK
      Choosing dopamine agonists in Parkinson's disease

      CLINICAL NEUROPHARMACOLOGY
    10. Jansen, PAF; Herings, RMC; Samson, MM; De Vreede, PL; Schuurmans-Daemen, LMPJ; Hovestadt, A; Verhaar, HJJ; Van Laar, T
      Quick titration of pergolide in cotreatment with domperidone is safe and effective

      CLINICAL NEUROPHARMACOLOGY
    11. Mungersdorf, M; Sommer, U; Sommer, M; Reichmann, H
      High-dose therapy with ropinirole in patients with Parkinson's disease

      JOURNAL OF NEURAL TRANSMISSION
    12. Hanna, PA; Ratkos, L; Ondo, WG; Jankovic, J
      Switching from pergolide to pramipexole in patients with Parkinson's disease

      JOURNAL OF NEURAL TRANSMISSION
    13. Tuite, P; Ebbitt, B
      Dopamine agonists

      SEMINARS IN NEUROLOGY
    14. O'Connor, WT
      Functional neuroanatomy of the ventral striopallidal GABA pathway - New sites of intervention in the treatment of schizophrenia

      JOURNAL OF NEUROSCIENCE METHODS
    15. Etminan, M; Samii, A; Takkouche, B; Rochon, PA
      Increased risk of somnolence with the new dopamine agonists in patients with Parkinson's disease - A meta-analysis of randomised controlled trials

      DRUG SAFETY
    16. Danoff, SK; Grasso, ME; Terry, PB; Flynn, JA
      Pleuropulmonary disease due to pergolide use for restless legs syndrome

      CHEST
    17. Swerdlow, NR; Platten, A; Shoemaker, J; Pitcher, L; Auerbach, P
      Effects of pergolide on sensorimotor gating of the startle reflex in rats

      PSYCHOPHARMACOLOGY
    18. Strafella, AP; Valzania, F; Nassetti, SA; Tropeani, A; Bisulli, A; Santangelo, M; Tassinari, CA
      Effects of chronic levodopa and pergolide treatment on cortical excitability in patients with Parkinson's disease: a transcranial magnetic stimulation study

      CLINICAL NEUROPHYSIOLOGY
    19. Stiasny, K; Wetter, TC; Trenkwalder, C; Oertel, WH
      Restless legs syndrome and its treatment by dopamine agonists

      PARKINSONISM & RELATED DISORDERS
    20. Stern, MB
      The early treatment of Parkinson's disease: levodopa, dopamine agonists orboth

      PARKINSONISM & RELATED DISORDERS
    21. Lledo, A
      Dopamine agonists: the treatment for Parkinson's disease in the XXI century?

      PARKINSONISM & RELATED DISORDERS
    22. Kondo, T
      Treatment of Parkinson's disease in Japan

      PARKINSONISM & RELATED DISORDERS
    23. Hubble, JP
      Pre-clinical studies of pramipexole: clinical relevance

      EUROPEAN JOURNAL OF NEUROLOGY
    24. Montplaisir, J; Denesle, R; Petit, D
      Pramipexole in the treatment of restless legs syndrome: a follow-up study

      EUROPEAN JOURNAL OF NEUROLOGY
    25. Finotti, N; Castagna, L; Moretti, A; Marzatico, F
      Reduction of lipid peroxidation in different rat brain areas after cabergoline treatment

      PHARMACOLOGICAL RESEARCH
    26. Rye, DB; Bliwise, DL; Dihenia, B; Gurecki, P
      Daytime sleepiness in Parkinson's disease

      JOURNAL OF SLEEP RESEARCH
    27. Walters, AS; Mandelbaum, DE; Lewin, DS; Kugler, S; England, SJ; Miller, M
      Dopaminergic therapy in children with restless legs/periodic limb movements in sleep and ADHD

      PEDIATRIC NEUROLOGY
    28. Zafonte, RD; Lexell, J; Cullen, N
      Possible applications for dopaminergic agents following traumatic brain injury: Part 1

      JOURNAL OF HEAD TRAUMA REHABILITATION
    29. Black, KJ; Mink, JW
      Response to levodopa challenge in Tourette syndrome

      MOVEMENT DISORDERS
    30. Kulisevsky, J; Garcia-Sanchez, C; Berthier, ML; Barbanoj, M; Pascual-Sedano, B; Gironell, A; Estevez-Gonzalez, B
      Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: A two-year follow-up study of previously untreated patients

      MOVEMENT DISORDERS
    31. Shulman, LM; Minagar, A; Rabinstein, A; Weiner, WJ
      The use of dopamine agonists in very elderly patients with Parkinson's disease

      MOVEMENT DISORDERS
    32. Malcolm, R; Kajdasz, DK; Herron, J; Anton, RF; Brady, KT
      A double-blind, placebo-controlled outpatient trial of pergolide for cocaine dependence

      DRUG AND ALCOHOL DEPENDENCE
    33. Haapaniemi, TH; Kallio, MA; Korpelainen, JT; Suominen, K; Tolonen, U; Sotaniemi, KA; Myllyla, VV
      Levodopa, bromocriptine and selegiline modify cardiovascular responses in Parkinson's disease

      JOURNAL OF NEUROLOGY
    34. Przuntek, H
      Non-dopaminergic therapy in Parkinson's disease

      JOURNAL OF NEUROLOGY
    35. Winkelmann, J; Trenkwalder, C
      Therapy of restless legs syndrome

      AKTUELLE NEUROLOGIE
    36. Crevits, L; Versijpt, J; Hanse, M; De Ridder, K
      Antisaccadic effects of a dopamine agonist as add-on therapy in advanced Parkinson's patients

      NEUROPSYCHOBIOLOGY
    37. Kameda, G; Dadmarz, M; Vogel, WH
      Influence of various drugs on the voluntary intake of nicotine by rats

      NEUROPSYCHOBIOLOGY
    38. Pinter, MM; Rutgers, AWF; Hebenstreit, E
      An open-label, multicentre clinical trial to determine the levodopa dose-sparing capacity of pramipexole in patients with idiopathic Parkinson's disease

      JOURNAL OF NEURAL TRANSMISSION
    39. Prikhojan, A; Brannan, T; Yahr, MD
      Comparative effects of repeated administration of dopamine agonists on circling behavior in rats

      JOURNAL OF NEURAL TRANSMISSION
    40. Di Sarno, A; Landi, ML; Marzullo, P; Di Somma, C; Pivonello, R; Cerbone, G; Lombardi, G; Colao, A
      The effect of quinagolide and cabergoline, two selective dopamine receptortype 2 agonists, in the treatment of prolactinomas

      CLINICAL ENDOCRINOLOGY
    41. Stacy, M
      Pharmacotherapy for advanced Parkinson's disease

      PHARMACOTHERAPY
    42. Izumi, T; Inoue, T; Kitagawa, N; Nishi, N; Shimanaka, S; Takahashi, Y; Kusumi, I; Odagaki, Y; Denda, K; Ohmori, T; Koyama, T
      Open pergolide treatment of tricyclic and heterocyclic antidepressant-resistant depression

      JOURNAL OF AFFECTIVE DISORDERS
    43. Brown, LK; Heffner, JE; Obbens, EAMT
      Transverse myelitis associated with restless legs syndrome and periodic movements of sleep responsive to an oral dopaminergic agent but not to intrathecal baclofen

      SLEEP
    44. Stiasny, K; Robbecke, J; Schuler, P; Oertel, WH
      Treatment of idiopathic restless legs syndrome (RLS) with the D2-agonist cabergoline - An open clinical trial

      SLEEP
    45. Fukuzaki, K; Kamenosono, T; Kitazumi, K; Nagata, R
      Effects of ropinirole on motor behavior in MPTP-treated common marmosets

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    46. Fukuzaki, K; Kamenosono, T; Nagata, R
      Effects of ropinirole on various Parkinsonian models in mice, rats, and cynomolgus monkeys

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    47. Marion, MH
      Drug treatments and motor complications in advanced stage Parkinson's disease

      REVUE NEUROLOGIQUE
    48. Gilbert, DL; Sethuraman, G; Sine, L; Peters, S; Salle, FR
      Tourette's syndrome improvement with pergolide in a randomized, double-blind, crossover trial

      NEUROLOGY
    49. Varsano, S; Gershman, M; Hamaoui, E
      Pergolide-induced dyspnea, bilateral pleural effusion and peripheral edema

      RESPIRATION
    50. Brooks, DJ
      Dopamine agonists: their role in the treatment of Parkinson's disease

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    51. Gilbert, DL; Sallee, FR; Sine, L; Sethuraman, G
      Behavioral and hormonal effects of low-dose pergolide in children and adolescents with Gilles de la Tourette's syndrome

      CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
    52. Hickey, J
      Restless legs syndrome

      CANADIAN FAMILY PHYSICIAN
    53. Tan, EK; Ondo, W
      Restless legs syndrome: Clinical features and treatment

      AMERICAN JOURNAL OF THE MEDICAL SCIENCES
    54. Sharma, JC; Ross, IN
      Long term role of pergolide as an adjunct therapy in Parkinson's disease: influence on disability, blood pressure, weight and levodopa syndrome

      PARKINSONISM & RELATED DISORDERS
    55. Jost, WH
      Equivalent doses of ropinirole and bromocriptine

      EUROPEAN JOURNAL OF NEUROLOGY
    56. Collado-Seidel, V; Winkelmann, J; Trenkwalder, C
      Aetiology and treatment of restless legs syndrome

      CNS DRUGS
    57. Kuzel, MD
      Ropinirole: A dopamine agonist for the treatment of Parkinson's disease

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    58. Champagne, SP; Coste, E; Peyriere, H; Nigond, J; Mania, E; Pons, M; Hillaire-Buys, D; Balmes, P; Blayac, JP; Davy, JM
      Chronic constrictive pericarditis induced by long-term bromocriptine therapy: Report of two cases

      ANNALS OF PHARMACOTHERAPY
    59. Ahlskog, JE; Uitti, RJ; O'Connor, MK; Maraganore, DM; Matsumoto, JY; Stark, KF; Turk, MF; Burnett, OL
      The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease

      MOVEMENT DISORDERS
    60. Picchietti, DL; Underwood, DJ; Farris, WA; Walters, AS; Shah, MM; Dahl, RE; Trubnick, LJ; Bertocci, MA; Wagner, M; Hening, WA
      Further studies on periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder

      MOVEMENT DISORDERS
    61. Montastruc, JL; Rascol, O; Senard, JM
      Treatment of Parkinson's disease should begin with a dopamine agonist

      MOVEMENT DISORDERS
    62. Ceballos-Baumann, AO
      New aspects in the treatment of Parkinson's disease

      NERVENHEILKUNDE
    63. Linazasoro, G; Obeso, JA; Gomez, JC; Martinez, M; Antonini, A; Leenders, KL
      Modification of dopamine D2 receptor activity by pergolide in Parkinson's disease: An in vivo study by PET

      CLINICAL NEUROPHARMACOLOGY
    64. Kunig, G; Pogarell, O; Moller, JC; Delf, M; Oertel, WH
      Pramipexole, a nonergot dopamine agonist, is effective against rest tremorin intermediate to advanced Parkinson's disease

      CLINICAL NEUROPHARMACOLOGY
    65. Kellett, MW; Steiger, MJ
      Deterioration in parkinsonism with low-dose pergolide

      JOURNAL OF NEUROLOGY
    66. Hobson, DE; Pourcher, E; Martin, WRW
      Ropinirole and pramipexole, the new agonists

      CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
    67. Canesi, M; Antonini, A; Mariani, CB; Tesei, S; Zecchinelli, AL; Barichella, M; Pezzoli, G
      An overnight switch to ropinirole therapy in patients with Parkinson's disease

      JOURNAL OF NEURAL TRANSMISSION
    68. Dethy, S; Laute, MA; Damhaut, P; Goldman, S
      Pergolide potentiates L-DOPA-induced dopamine release in rat striatum after lesioning with 6-hydroxydopamine

      JOURNAL OF NEURAL TRANSMISSION
    69. Simms, MS; Simms, MH
      Iliocaval venous obstruction in pergolide-induced retroperitoneal fibrosis

      PHLEBOLOGY
    70. Gallagher, IM; Clow, A; Jenner, P; Glover, V
      Long-term effects of pergolide and (-)-deprenyl on H-3-mazindol and H-3-spiperone binding in rat brains

      NEUROBIOLOGY OF AGING
    71. Gallagher, IM; Clow, A; Jenner, P; Glover, V
      Effect of long-term administration of pergolide and (-)-deprenyl on age related decline in hole board activity and antioxidant enzymes in rats.

      BIOGENIC AMINES
    72. Benes, H; Kurella, B; Kummer, J; Kazenwadel, J; Selzer, R; Kohnen, R
      Rapid onset of action of levodopa in restless legs syndrome: A double-blind, randomized, multicenter, crossover trial

      SLEEP
    73. Chesson, AL; Wise, M; Davila, D; Johnson, S; Littner, M; Anderson, WM; Hartse, K; Rafecas, J
      Practice parameters for the treatment of Restless Legs Syndrome and periodic limb movement disorder

      SLEEP
    74. Brandabur, MM
      Current therapy in Parkinson's disease

      SURGICAL NEUROLOGY
    75. Entezari-Taher, M; Singleton, JR; Jones, CR; Meekins, G; Petajan, JH; Smith, AG
      Changes in excitability of motor cortical circuitry in primary restless legs syndrome

      NEUROLOGY
    76. Goetz, CG; Blasucci, L; Stebbins, GT
      Switching dopamine agonists in advanced Parkinson's disease - Is rapid titration preferable to slow?

      NEUROLOGY
    77. Chokroverty, S; Jankovic, J
      Restless legs syndrome - A disease in search of identity

      NEUROLOGY
    78. Montplaisir, J; Nicolas, A; Denesle, R; Gomez-Mancilla, B
      Restless legs syndrome improved by pramipexole - A double-blind randomizedtrial

      NEUROLOGY
    79. Arnold, G; Kupsch, A
      High dose therapy of a patient with Parkinson's disease with the novel dopamine agonist Pramipexole allows reduction of L-dopa down to nil

      NERVENARZT
    80. Ahlskog, JE
      Medical treatment of later-stage motor problems of Parkinson disease

      MAYO CLINIC PROCEEDINGS
    81. Shaunak, S; Wilkins, A; Pilling, JB; Dick, DJ
      Pericardial, retroperitoneal, and pleural fibrosis induced by pergolide

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    82. Perachon, S; Schwartz, JC; Sokoloff, P
      Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D-1, D-2 and D-3 receptors

      EUROPEAN JOURNAL OF PHARMACOLOGY
    83. Iida, M; Miyazaki, I; Tanaka, K; Kabuto, H; Iwata-Ichikawa, E; Ogawa, N
      Dopamine D2 receptor-mediated antioxidant and neuroprotective effects of ropinirole, a dopamine agonist

      BRAIN RESEARCH
    84. HOERGER TJ; BALA MV; ROWLAND C; GREER M; CHRISCHILLES EA; HOLLOWAY RG
      COST-EFFECTIVENESS OF PRAMIPEXOLE IN PARKINSONS-DISEASE IN THE US

      PharmacoEconomics
    85. SWERDLOW NR; TAAID N; OOSTWEGEL JL; RANDOLPH E; GEYER MA
      TOWARDS A CROSS-SPECIES PHARMACOLOGY OF SENSORIMOTOR GATING - EFFECTSOF AMANTADINE, BROMOCRIPTINE, PERGOLIDE AND ROPINIROLE ON PREPULSE INHIBITION OF ACOUSTIC STARTLE IN RATS

      Behavioural pharmacology
    86. WINKELMANN J; WETTER TC; STIASNY K; OERTEL WH; TRENKWALDER C
      TREATMENT OF RESTLESS LEG SYNDROME WITH PERGOLIDE - AN OPEN CLINICAL-TRIAL

      Movement disorders
    87. HAGELL P; ODIN P; VINGE E
      PREGNANCY IN PARKINSONS-DISEASE - A REVIEW OF THE LITERATURE AND A CASE-REPORT

      Movement disorders
    88. Kulisevsky, J; Lopez-Villegas, D; Garcia-Sanchez, C; Barbanoj, M; Gironell, A; Pascual-Sedano, B
      A six-month study of pergolide and levodopa in de novo Parkinson's diseasepatients

      CLINICAL NEUROPHARMACOLOGY
    89. JORG J
      TREATMENT OF PARKINSONS-DISEASE WITH ALPHA-DIHYDROERGOCRYPTINE IN NEUROLOGICAL PRACTICE - RESULTS OF AN OBSERVATIONAL STUDY

      Aktuelle Neurologie
    90. POGARELL O; OERTEL WH
      NEW DOPAMINE AGONISTS FOR THE TREATMENT OF PARKINSONS-DISEASE

      Aktuelle Neurologie
    91. STAEDT J; HUNERJAGER H; RUTHER E; STOPPE G
      PERGOLIDE - TREATMENT OF CHOICE IN RESTLESS-LEGS-SYNDROME (RLS) AND NOCTURNAL-MYOCLONUS-SYNDROME (NMS) - LONG-TERM FOLLOW-UP ON PERGOLIDE -SHORT COMMUNICATION

      Journal of neural transmission
    92. MULLER U; VONCRAMON DY; POLLMANN S
      D1-VERSUS D2-RECEPTOR MODULATION OF VISUOSPATIAL WORKING-MEMORY IN HUMANS

      The Journal of neuroscience
    93. PIETA J; MILLAR T; ZACHARIAS J; FINE A; KRYGER M
      EFFECT OF PERGOLIDE ON RESTLESS LEGS AND LEG MOVEMENTS IN SLEEP IN UREMIC PATIENTS

      Sleep
    94. POTTER DE; OGIDIGBEN MJ; CHU TC
      LISURIDE ACTS AT MULTIPLE SITES TO INDUCE OCULAR HYPOTENSION AND MYDRIASIS

      Pharmacology
    95. LIEBERMAN A; OLANOW CW; SETHI K; SWANSON P; WATERS CH; FAHN S; HURTIG H; YAHR M
      A MULTICENTER TRIAL OF ROPINIROLE AS ADJUNCT TREATMENT FOR PARKINSONS-DISEASE

      Neurology
    96. BECKER PM; ONDO W; SHARON D
      ENCOURAGING INITIAL RESPONSE OF RESTLESS LEGS SYNDROME TO PRAMIPEXOLE

      Neurology
    97. YAMAMOTO M
      DO DOPAMINE AGONISTS PROVIDE NEUROPROTECTION

      Neurology
    98. POEWE W
      ADJUNCTS TO LEVODOPA THERAPY - DOPAMINE AGONISTS

      Neurology
    99. PAHWA R; KOLLER WC
      ADVANCES IN THE TREATMENT OF PARKINSONS-DISEASE

      Medicamentos de actualidad
    100. YOSHIMURA N; MIZUTA E; YOSHIDA O; KUNO S
      THERAPEUTIC EFFECTS OF DOPAMINE D-1 D-2 RECEPTOR AGONISTS ON DETRUSORHYPERREFLEXIA IN ETHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE-LESIONED PARKINSONIAN CYNOMOLGUS MONKEYS/

      The Journal of pharmacology and experimental therapeutics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/02/20 alle ore 18:11:55